Merus N.v. buy BiotechBee
Start price
24.06.23
/
70%
€23.20
Target price
30.04.26
€40.00
Performance (%)
117.67%
Price
22.07.24
€51.50
Summary
This prediction is currently active. With a performance of 117.67% the BUY prediction by BiotechBee is a big success. This prediction currently runs until 30.04.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Merus N.v. | - | - | - |
iShares Core DAX® | -0.543% | 1.491% | 13.638% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% |
According to BiotechBee what are the pros and cons of Merus N.v. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Merus N.v. diskutieren
Buy mit Kursziel 40,0